Author Correction: A broadly protective antibody targeting gammaherpesvirus gB

Researchers published an author correction regarding a study on a broadly protective antibody targeting gammaherpesvirus gB on June 09, 2026. The correction, published online in Nature, addresses specific details within the original research paper, which focused on advancements in virology and immunology. The study's findings were significant for their potential to develop new therapeutic strategies against gammaherpesvirus infections, a group of viruses that includes Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus. The antibody in question targets the glycoprotein B (gB) of these viruses, a crucial component for viral entry into host cells. The correction ensures the scientific community has the most accurate and precise information available regarding the antibody's mechanism of action and its potential efficacy. This level of scientific rigor is essential for the advancement of medical research and the development of effective treatments for viral diseases.